162 results
Page 3 of 9
6-K
EX-99
yqjc8jgyptvhr9nl5
13 Oct 21
BioLineRx Announces Positive Results from
8:37am
6-K
EX-10.1
8lg0m
3 Sep 21
Current report (foreign)
4:30pm
6-K
EX-99
gkb o4r02d
18 Aug 21
BioLineRx Reports Second Quarter 2021 Financial Results
7:01am
6-K
EX-99
ae43 7hx25
18 Aug 21
BioLineRx Reports Second Quarter 2021 Financial Results
7:01am
6-K
EX-99
m74zewqmrm1fr028v87b
21 Jan 21
Amended and Restated Underwriting Agreement
4:32pm
6-K
EX-99
y5i8h8 qr4w5hslscz
16 Dec 20
BioLineRx Announces Final Results from Phase 2a
6:02am
6-K
EX-99
2ivm lhc8xtor
29 Oct 20
BioLineRx Announces Initiation of Phase 2 Clinical Trial
8:45am
6-K
EX-10.1
ikry7gs gsqko1v
25 Sep 20
Current report (foreign)
4:33pm
6-K
EX-99
dnnwwvn
3 Jun 20
Current report (foreign)
8:30am
6-K
EX-99
1cs32ub1lt9py8wljlpi
28 May 20
Current report (foreign)
11:56am
6-K
EX-99
a7cjiy u9
27 May 20
BioLineRx Announces Publication of Data from Ongoing
7:00am
6-K
EX-99
vtxcwfpp
14 Jan 20
BioLineRx Receives Orphan Drug Designation for Motixafortide (BL-8040) for the Treatment of
7:00am
6-K
EX-1
fz66lkujf8o fnqtx
28 May 19
Current report (foreign)
7:04am
6-K
EX-99
eb5yal 15mri
7 Feb 19
As Representative of the several Underwriters
12:00pm
6-K
EX-99
culyuv
7 Feb 19
As Representative of the several Underwriters
12:00pm